Clinical Trial

Type 1 Diabetes and Obstructive Sleep Apnea

Study acronym: T1D and OSA
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-03-31; most recent amendment 2026-01-15.
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT06915831
Lead Sponsor University of Chicago
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Sleep Apnea, Obstructive, Type 1 Diabetes (T1D)
Enrollment 40 participants
Start Date 2025-11-10
Primary Completion 2029-08-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-20